PregnancyPumpingNCT00393640
Early and Regular Breast Milk Expression to Help Establish Lactation After Delivery: a Randomized Controlled Trial
A study testing Early and regular breast milk expression in people with Pregnancy and Breastfeeding, run by National University Hospital, Singapore at 1 site in Singapore.
Trial summary
The purpose of this study is to determine whether early start of either breastfeeding or breast milk expression may positively affect milk production later in lactation. 120 breastfeeding mothers will be recruited and randomized into 4 groups (2 groups with preterm deliveries) and 2 groups with term deliveries. Read more about this study
- Who is it for?
- Ages Up to 55 years, women only
- Conditions the study is for
- Pregnancy, Breastfeeding
- What is being tested?
- Early and regular breast milk expression
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 120 participants
- Where
- 1 siteSingapore
- Study dates
- Feb 2005to Mar 2009
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Up to 55 years
- Women only
- No healthy volunteers
- Child, Adult
Who may be able to join
- 60 women with preterm pregnancies who want to breastfeed their babies will be recruited and 60 women with term pregnancies who want to breastfeed their babies will be recruited and randomized.
Who cannot join
- Those with maternal diabetes and hyperprolactinaemia, as well as fetal congenital anomalies and multiple pregnancies will be excluded.
Trial locations and contacts
1 site in 1 country.
About this study
The purpose of this study is to determine whether early start of either breastfeeding or breast milk expression may positively affect milk production later in lactation.
120 breastfeeding mothers will be recruited and randomized into 4 groups (2 groups with preterm deliveries) and 2 groups with term deliveries. One group will be given a breast pump to pump early and regularly. the second group will be encouraged to breastfeed in response to baby's cues. Breast milk samples will be collected at the end of a week.
Read the detailed description
The initiation of lactation in women depends on the growth of the glandular tissue of the breast (mammogenesis) and the differentiation of the mammary secretory epithelial cells (lactocytes) during pregnancy (lactogenesis I). After birth, the continuous nourishment of the fetus from the mother via the umbilical cord is replaced by the equally important but intermittent nourishment from the mother's breast. The onset of copious milk production (lactogenesis II) is closely coupled to the factors controlling the birth process. In mothers who have delivered pre-term, mammogenesis and lactogenesis I may be truncated and close consideration must be given to all physiological aspects of this complex process when assisting preterm mothers to establish successful lactation. In Singapore, the problem is not restricted to mothers of preterm babies. In a nation-wide survey by the Health Promotion Board in 2001, inability to produce enough breast milk was stated as the reason for not breastfeeding by 53% of mothers two months after birth.
The hypothesis of this study is that early, regular and complete emptying of the breasts can hasten and improve the establishment of lactogenesis II after preterm and term deliveries.
It aims to compare the effect of early and regular breast milk expression on the success and timing of establishment of lactogenesis II compared with routine breastfeeding practice in mothers after preterm and term deliveries.
The second aim is to study the effect of early and regular breast milk expression on blood prolactin and progesterone levels in women after preterm and term deliveries.
The final aim is to study the volume of breast milk produced and fed to babies after preterm and term deliveries.
80 women with preterm deliveries (28 weeks to 36 weeks gestation) and 80 women with term deliveries (after 37 weeks gestation) will be recruited and randomised with minimization by the stratification factors of previous live births and breastfeeding experience.
Groups A or C mothers will be given a breast pump to start expressing within one hour after delivery and thereafter every two to three hours besides breastfeeding their babies directly.
Groups B or D mothers will breastfeed according to routine hospital protocol. Standard postnatal nursing care will be followed. 7 days of breast milk samples (of 1ml in the morning and one ml in the evening )will be collected at the end of the 8th day. The details of the delivery, birth weight, and neonatal condition will be collected prospectively at birth. Mothers will be given a neonatal feeding diary to record the frequency and amount of breast milk expressed, the frequency and duration of direct breast feeds, and any other fluids fed to their babies in the first week. They will be asked to record their own perception of when their breast milk flow was established. The babies will be weighed on Day 7.
The primary outcomes are:
- Successful initiation of lactation as determined by lactogenesis II markers
- Successful initiation of lactation as determined by maternal perception
- timing of successful establishment of lactogenesis II.
All statistical analyses will be conducted by SPSS 11.0. The differences in successful initiation of lactation as determined by lactogenesis II markers and the successful initiation of lactation as determined by maternal perception between the 2 groups will be assessed by Chi-Square or Fisher Exact tests. A logistic regression analysis will be performed to adjust for relevant covariates. 2 sample t-tests will be performed to determine the differences between the 2 groups in the timing of successful establishment of lactogenesis II, volumes of colostrums and milk expressed and fed and weight change in baby 7 days after birth when normality assumptions are satisfied. Otherwise the Mann Whitney U test will be applied. A multiple regression analysis will be carried out to take into account relevant covariates. Statistical significance is set at p <0.05.
Outcomes and advantages of the project:
- If early and regular expression of breast milk can speed up or improve the chance of successful initiation of lactogenesis II, it can be a useful aid to women planning to breastfeed their babies, especially if they deliver prematurely.
- This study will help us to determine the normal timing of establishment of lactogenesis II in Singaporean women after term and preterm delivery. Validated and precise breast milk markers of lactogenesis II will be used and compared with simple maternal perception. This knowledge will help dispel the many myths regarding Asian women and breastfeeding.
- Currently, the actual physiological nutritional requirements of a breastfed newborn is not known. In our study, the volume of breast milk produced daily and fed to the baby in the first week will be measured in after both term and preterm delivery. This can be correlated to the weight change of the newborns to determine how much breast milk a neonate normally requires.
This will be the first of a series of collaborative projects on the various aspects of the science of human lactation between the Lactation Research Laboratory at the University of Western Australia and the Early Childhood Programming Group of the National University of Singapore
- Conditions
- Pregnancy, Breastfeeding
- Being tested
- Early and regular breast milk expression
- Keywords
- Early Initiation of lactogenesis II
- Medical subject headings
- Breast Feeding
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Early and regular breast milk expressionProcedure or surgery
Breast pump given to be used on regular intervals
| Study group | Role | What they receive |
|---|---|---|
| A | Active comparator | Breast pump given and used on regular intervals Receives: Procedure: Early and regular breast milk expression |
| B | No intervention | Not described |
| c | Active comparator | Breast pump given to be used on regular interval Receives: Procedure: Early and regular breast milk expression |
| D | No intervention | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Successful initiation of lactation as determined by lactogenesis II markers.
Measured: 7 days postpartum
Successful initiation of lactation as determined by maternal perception.
Measured: 7 days postpartum
Secondary outcomes (2)
Volume of colostrum and milk expressed, and fed to the neonate
Measured: 7 days postpartum
Weight change in baby 7 days after birth. Statistical considerations
Measured: 7 days postpartum
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Oct 2006 (estimated)
- Study startFeb 2005
- Primary completionOct 2008
- Study completionMar 2009
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for PregnancyStudies of the same condition, open and under way.
- More trials run by National University Hospital, SingaporeThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 120 participants (estimated)
Sponsor and investigators
- Lead sponsor
- National University Hospital, Singapore
- Sponsor type
- University, hospital or other
- Collaborators
- The University of Western Australia
- Investigators
- Yap S Chong, MRACOG, MMED, Principal investigator, National University Hospital, O & G
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00393640
- Sponsor's protocol ID
- NHG RPR 04027
- Acronym
- Pumping
- Status last verified
- Sep 2009
- First submitted
- 27 Oct 2006
- Last updated
- 21 Sep 2009
- Results posted
- No
- Data monitoring committee
- Yes
Publications
Cregan MD, De Mello TR, Kershaw D, McDougall K, Hartmann PE. Initiation of lactation in women after preterm delivery. Acta Obstet Gynecol Scand. 2002 Sep;81(9):870-7. doi: 10.1034/j.1600-0412.2002.810913.x.
PubMed 12225305
Study at a glance
From the registry record, last updated by the sponsor on 21 Sep 2009. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Early and Regular Breast Milk Expression to Help Establish Lactation After Delivery: a Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT00393640
- Acronym / sponsor ID
- Pumping / NHG RPR 04027
- Conditions
- Pregnancy, Breastfeeding
- Keywords
- Early Initiation of lactogenesis II
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 120 participants (estimated)
- Lead sponsor
- National University Hospital, SingaporeUniversity, hospital or other
- Collaborators
- The University of Western Australia
- Study start
- Feb 2005
- Primary completion
- Oct 2008 (actual)
- Study completion
- Mar 2009 (actual)
- First posted
- 30 Oct 2006 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to determine whether early start of either breastfeeding or breast milk expression may positively affect milk production later in lactation.
120 breastfeeding mothers will be recruited and randomized into 4 groups (2 groups with preterm deliveries) and 2 groups with term deliveries. One group will be given a breast pump to pump early and regularly. the second group will be encouraged to breastfeed in response to baby's cues. Breast milk samples will be collected at the end of a week.
Detailed description
The initiation of lactation in women depends on the growth of the glandular tissue of the breast (mammogenesis) and the differentiation of the mammary secretory epithelial cells (lactocytes) during pregnancy (lactogenesis I). After birth, the continuous nourishment of the fetus from the mother via the umbilical cord is replaced by the equally important but intermittent nourishment from the mother's breast. The onset of copious milk production (lactogenesis II) is closely coupled to the factors controlling the birth process. In mothers who have delivered pre-term, mammogenesis and lactogenesis I may be truncated and close consideration must be given to all physiological aspects of this complex process when assisting preterm mothers to establish successful lactation. In Singapore, the problem is not restricted to mothers of preterm babies. In a nation-wide survey by the Health Promotion Board in 2001, inability to produce enough breast milk was stated as the reason for not breastfeeding by 53% of mothers two months after birth.
The hypothesis of this study is that early, regular and complete emptying of the breasts can hasten and improve the establishment of lactogenesis II after preterm and term deliveries.
It aims to compare the effect of early and regular breast milk expression on the success and timing of establishment of lactogenesis II compared with routine breastfeeding practice in mothers after preterm and term deliveries.
The second aim is to study the effect of early and regular breast milk expression on blood prolactin and progesterone levels in women after preterm and term deliveries.
The final aim is to study the volume of breast milk produced and fed to babies after preterm and term deliveries.
80 women with preterm deliveries (28 weeks to 36 weeks gestation) and 80 women with term deliveries (after 37 weeks gestation) will be recruited and randomised with minimization by the stratification factors of previous live births and breastfeeding experience.
Groups A or C mothers will be given a breast pump to start expressing within one hour after delivery and thereafter every two to three hours besides breastfeeding their babies directly.
Groups B or D mothers will breastfeed according to routine hospital protocol. Standard postnatal nursing care will be followed. 7 days of breast milk samples (of 1ml in the morning and one ml in the evening )will be collected at the end of the 8th day. The details of the delivery, birth weight, and neonatal condition will be collected prospectively at birth. Mothers will be given a neonatal feeding diary to record the frequency and amount of breast milk expressed, the frequency and duration of direct breast feeds, and any other fluids fed to their babies in the first week. They will be asked to record their own perception of when their breast milk flow was established. The babies will be weighed on Day 7.
The primary outcomes are:
- Successful initiation of lactation as determined by lactogenesis II markers
- Successful initiation of lactation as determined by maternal perception
- timing of successful establishment of lactogenesis II.
All statistical analyses will be conducted by SPSS 11.0. The differences in successful initiation of lactation as determined by lactogenesis II markers and the successful initiation of lactation as determined by maternal perception between the 2 groups will be assessed by Chi-Square or Fisher Exact tests. A logistic regression analysis will be performed to adjust for relevant covariates. 2 sample t-tests will be performed to determine the differences between the 2 groups in the timing of successful establishment of lactogenesis II, volumes of colostrums and milk expressed and fed and weight change in baby 7 days after birth when normality assumptions are satisfied. Otherwise the Mann Whitney U test will be applied. A multiple regression analysis will be carried out to take into account relevant covariates. Statistical significance is set at p <0.05.
Outcomes and advantages of the project:
- If early and regular expression of breast milk can speed up or improve the chance of successful initiation of lactogenesis II, it can be a useful aid to women planning to breastfeed their babies, especially if they deliver prematurely.
- This study will help us to determine the normal timing of establishment of lactogenesis II in Singaporean women after term and preterm delivery. Validated and precise breast milk markers of lactogenesis II will be used and compared with simple maternal perception. This knowledge will help dispel the many myths regarding Asian women and breastfeeding.
- Currently, the actual physiological nutritional requirements of a breastfed newborn is not known. In our study, the volume of breast milk produced daily and fed to the baby in the first week will be measured in after both term and preterm delivery. This can be correlated to the weight change of the newborns to determine how much breast milk a neonate normally requires.
This will be the first of a series of collaborative projects on the various aspects of the science of human lactation between the Lactation Research Laboratory at the University of Western Australia and the Early Childhood Programming Group of the National University of Singapore
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| A | Active comparator | Procedure: Early and regular breast milk expressionBreast pump given and used on regular intervals |
| B | No intervention | – |
| c | Active comparator | Procedure: Early and regular breast milk expressionBreast pump given to be used on regular interval |
| D | No intervention | – |
Who may qualify
- Ages
- Up to 55 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (1 listed)
- 60 women with preterm pregnancies who want to breastfeed their babies will be recruited and 60 women with term pregnancies who want to breastfeed their babies will be recruited and randomized.
Key exclusion criteria (1 listed)
- Those with maternal diabetes and hyperprolactinaemia, as well as fetal congenital anomalies and multiple pregnancies will be excluded.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Early and regular breast milk expressionBreast pump given to be used on regular intervals | Procedure or surgery | A, c |
Primary outcome
Successful initiation of lactation as determined by lactogenesis II markers.
Time frame: 7 days postpartum
Successful initiation of lactation as determined by maternal perception.
Time frame: 7 days postpartum
2 secondary outcomes
Volume of colostrum and milk expressed, and fed to the neonate
Time frame: 7 days postpartum
Weight change in baby 7 days after birth. Statistical considerations
Time frame: 7 days postpartum
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Sep 2009.
- Background: PubMed 12225305Cregan MD, De Mello TR, Kershaw D, McDougall K, Hartmann PE. Initiation of lactation in women after preterm delivery. Acta Obstet Gynecol Scand. 2002 Sep;81(9):870-7. doi: 10.1034/j.1600-0412.2002.810913.x.
Related trials for Pregnancy
RecruitingPhase 2
IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence
Fallopian Tube Carcinoma, Ovarian Carcinoma
Not yet recruitingObservational study
Assessment of Intelligent Algorithms for Detection, Diagnosis and Risk Stratification of Tumors of the Kidney and Prostate
Kidney Cancers, Prostate Cancer
RecruitingPhase 3
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Active, not recruitingPhase 3
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v7
Active, not recruitingPhase 1/2
AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)
Advanced/Metastatic Clear Cell Renal Cell Carcinoma, Recurrence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Yap S Chong, MRACOG, MMED principal investigator
National University Hospital, O & G
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Early and regular breast milk expression in people with Pregnancy and Breastfeeding, run by National University Hospital, Singapore at 1 site in Singapore.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Sep 2009. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Successful initiation of lactation as determined by lactogenesis II markers. (time frame: 7 days postpartum). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00393640, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Sep 2009.